MoonLake Immunotherapeutics
MLTX
#5901
Rank
NZ$1.78 B
Marketcap
NZ$25.21
Share price
0.41%
Change (1 day)
-72.83%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -NZ$0.37 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.23 Billion a decrease over its 2023 earnings that were of -NZ$93.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.37 Billion60.62%
2024 -NZ$0.23 Billion142.55%
2023 -NZ$93.41 Million-16.81%
2022 -NZ$0.12 Billion